Objective: Liver handling of thyroid hormones (TH) has been known to alter significantly during fasting. This study investigates whether renal handling of TH is also changed during fasting. Methods: We measured urinary excretion rates and clearances of free tri-iodothyronine (T 3 ) and free thyroxine (T 4 ) in healthy subjects prior to and on the third day of fasting. Results: During fasting, both mean T 3 and T 4 urinary excretion decreased significantly to a mean value of 42% of control. Also, total and free (F) serum T 3 concentrations declined significantly, but serum T 4 did not change. Both FT 3 and FT 4 clearance decreased significantly during fasting (62% and 42% of control). The fasting-induced decrease in uric acid clearance correlated well with the decrease in FT 3 clearance (r = 0.94; P < 0.001). Serum concentrations of non-esterified fatty acids (NEFA) were significantly elevated during fasting. Conclusions: The findings cannot be fully explained by the fasting-induced decrease in serum T 3 , and are in accordance with inhibition of uptake of T 3 and T 4 at the basolateral membrane of the tubular cell. This inhibition may be caused by a decreased energy state of the tubular cell and by other factors such as ketoacidosis and/or increased NEFA concentrations during fasting.
Introduction
In man, eighty percent of plasma tri-iodothyronine (T 3 ), the bioactive thyroid hormone, is produced outside the thyroid by deiodination of thyroxine (T 4 ), which is the main secretory product of the thyroid gland (1). Both liver and kidney cells contain high amounts of the enzyme, type I 5 0 -deiodinase (2, 3), that converts T 4 to T 3 . However, before this intracellular conversion can take place, entry over the plasma membrane into liver and kidney cells has to occur. We showed that uptake of T 4 , but also of T 3 and reverse (r) T 3 into liver cells is mediated by an active transport process that is dependent on ATP and on the Na + -gradient (4). This process appeared to be the rate-limiting step in the metabolism of thyroid hormones (5).
During fasting and non-thyroidal illness (NTI), a decrease in serum T 3 concentration, a rise in rT 3 and mostly unchanged free (F) and total (T) serum T 4 concentrations are seen (6). These alterations in serum thyroid hormone levels are explained by unchanged plasma T 4 and rT 3 production rates, combined with both decreased T 4 to T 3 conversion and rT 3 degradation in the liver (6). In addition to decreased 5 0 -deiodinase activity, catalyzing both T 4 to T 3 formation and rT 3 degradation (7), decreased uptakes of T 4 and rT 3 into the liver have been described as causes for these alterations (6). In a study using a three compartment model for thyroid hormone kinetics, we showed that during caloric deprivation, transport of T 4 into the fast equilibrating compartment (composed of liver and kidney) was diminished (8), resulting in a decline of substrate for T 3 production and consequently leading to a lowered plasma T 3 production rate.
Much attention has been given to the changes in liver handling of thyroid hormones seen in NTI and during fasting (6, 9, 10). However, it is not known whether changes in renal handling of thyroid hormones occur during fasting and NTI. In this study, we aim to illuminate some aspects of renal excretion of thyroid hormones during fasting in healthy subjects, thus creating an experimental form of NTI.
Materials, subjects and methods

Subjects
Four (2 female) healthy volunteers aged 20 to 25 years participated in this study. Thyroid function as evaluated by serum concentrations of TT 4 , FT 4 , TT 3 , FT 3 , rT 3 and thyrotropin (TSH) was normal in all subjects. Apart from oral contraceptives used by subject 4, no medication was taken. Indices of nutritional status prior to the fast were normal in all subjects studied (normal serum concentrations of T 3 , creatinine, uric acid, urea (5.65 Ϯ 1.06 mmol/l) and free fatty acids).
Study design
On day 0 a normal diet was consumed. Urine was collected for 24 h and a blood sample was taken. From day 1 to 3, the subjects fasted, but a maximal caloric intake of 60 kcal per day in the form of low fat bouillon was allowed. On day 3, another 24-h urine sample was collected and a blood sample was taken. All blood samples were taken at the mid-point of a 24-h collection period.
Urine analysis
Samples of the 24-h urine collection were stored at ¹20 ЊC until analysis. Uric acid, creatinine and urea concentrations were measured on an EPOS analyzer from Eppendorf (Hamburg, Germany). Urinary T 4 and T 3 concentrations were determined by RIA. Using a highly specific antibody, no thyroid hormone conjugates could be measured. In a set of 3 experiments, the recovery of thyroid hormone added to charcoal-treated urine was measured. A regression line: y = 0.97x-0.06, P = 0.04 was obtained. Changing the urinary pH by adding 50 ml of either 0.1 mol/l NaOH or 0.1 mol/l HCl to 950 ml urine did not influence the recovery of added thyroid hormone.
Serum analysis
Serum was stored at ¹20 ЊC until analysis. Serum TT 4 , TT 3 , and rT 3 were determined by RIA. Serum FT 4 was determined using an Amerlite kit from Johnson and Johnson Clinical Diagnostics Ltd (Amersham, Bucks, UK). The serum FT 3 fraction was determined by equilibrium dialysis according to Sterling and Brenner (11), with minor modifications (12). Serum TSH was determined using a TSH Amerlite kit (Johnson and Johnson Clinical Diagnostics Ltd). Urea, creatinine and uric acid were determined on a Chem 1 analyzer from Technicon (Tarrytown, NY, USA). Serum non-esterified fatty acids (NEFA) were measured using a NEFA C-test (Wako Chemicals, Tokyo, Japan).
Calculations and statistical analysis
Clearances of creatinine, uric acid, FT 3 and FT 4 were calculated using the formula U*V/P*1.44, where U is urinary concentration in mol/l, V is urinary volume of 24-h collection period in ml/24 h and P is plasma concentration in mol/l (13).
The significance of differences was determined by Student's t-test for paired observations. All data are expressed as means Ϯ S.D. A P value < 0.05 was considered statistically significant. Table 1 shows the parameters measured to evaluate thyroid function before and on the third day of fasting. Data on all subjects follow the same trend. T 3 concentrations are significantly lowered, and those of rT 3 are elevated after fasting. Total and free T 4 concentrations are unchanged. Serum TSH levels decline but all values remain within the reference range.
Results
In Table 2 , urinary excretion of T 3 and T 4 on both the control day and the third day of fasting are shown. Urinary excretion of both T 3 and T 4 is significantly diminished during fasting. Since urinary excretion is dependent on the filtration of plasma free hormone, changes in plasma concentrations will lead to changes in urinary excretion. Therefore, renal clearances of FT 3 and FT 4 are given. In the control period, renal clearance of FT 3 is significantly greater and that of FT 4 significantly smaller than the creatinine clearance. Fasting causes a decline in both renal clearances,
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www.eje.org Table 1 Serum thyroid function parameters prior to and on the third day of fasting. Data represent the mean Ϯ S.D. of 4 healthy subjects, except for serum rT 3 data: n = 3, before and on the third day of fasting. resulting in a FT 3 renal clearance that is no longer statistically different from the creatinine clearance (P = 0.1616).
Control
In Table 3 , serum concentrations, 24-h urinary excretion rates and clearance of uric acid are given. Serum uric acid concentrations rise significantly during fasting, but urinary excretion and clearance of uric acid decrease significantly. Figure 1 shows the correlation between renal clearances of FT 3 and uric acid (r = 0.94, P < 0.001).
Serum NEFA levels, measured in 3 subjects, rise significantly after 3 days of fasting (0.27 Ϯ 0.22 mmol/l in the control period versus 1.03 Ϯ 0.46 mmol/l in the fasted state, P = 0.0305).
Discussion
In this study, we investigated renal handling of thyroid hormones during fasting in man. Our control values of T 4 and T 3 excretion and renal clearances of these hormones in healthy euthyroid persons are in good agreement with reported values obtained in other studies (14-20). The FT 3 renal clearance in healthy humans is significantly greater than the creatinine clearance, the latter being a measure of the glomerular filtration rate (GFR), whereas FT 4 clearance is significantly lower, as has been found by others (14-20) and in this study. These data are consistent with active (tubular) excretion of T 3 into the urine and effective reabsorption of T 4 from the glomerular filtrate in the fed man.
We showed a dramatic decline in urinary excretion of both T 3 and T 4 during fasting. Since the urinary fate of a substance is dependent on its serum concentration, calculation of the renal clearance is needed to correct for differences in serum concentrations. When calculating the renal clearances, we and others (17-20) used the serum free hormone concentrations since only the free fraction of these hormones is available for glomerular filtration and cellular uptake. The decrease in FT 3 and FT 4 clearance during fasting indicates that, in addition to decreased T 3 serum concentrations, other factors are responsible for the lowered excretion of thyroid hormones into the urine.
Figure 2 depicts a schematic proximal tubule cell of the kidney. Urinary T 3 and T 4 may be considered as the sum of glomerularly filtered thyroid hormone (TH) (pathway 1), plus TH excreted to the urine (pathway 2), minus reabsorbed TH (pathway 3). Glomerular filtration of free TH results in a free hormone concentration, at the start of the proximal tubule, equal to that in serum. Reabsorption of both T 4 and T 3 occurs subsequently, but also uptake at the basolateral membrane of the proximal tubule cell takes place. Cavalieri et al. (21) showed that, in humans, the unidirectional renal T 3 uptake rate is about 50 nmol per day. This rate is far greater than the filtered load per day, which is around 0.8 nmol per day (serum FT 3 times GFR, this study). Furthermore, Ferguson et al. reported unchanged T 4 uptake in the isolated perfused rat kidney after a decrease in the GFR (22). These observations indicate that thyroid hormones may be taken up at the basolateral membrane of the tubule cell and/or in other kidney cells. Thus, in the fed condition, uptake of TH takes place at both the luminal membrane (reabsorption, pathway 3) and the basolateral membrane (pathway 4). Deiodination of T 4 to T 3 (pathway 5), excretion into the urine (pathway 2) or secretion to the blood (pathway 6) may follow subsequently.
The lowered excretion and clearances of T 3 and T 4 during fasting may either be caused by stimulation of pathway 3, or by a decrease in pathway 2. It is unlikely that in a state of energy depletion, such as fasting, pathway 3 will be stimulated, as during caloric deprivation in humans uptake in the rapid equilibrating compartment (liver and kidney) is decreased (8). Therefore, a decrease in pathway 2 may be a much more likely explanation for the findings in this study. In a recent study, we showed that cellular efflux of thyroid hormones is a passive process, not influenced by changes in cellular ATP content, and driven by the intracellular free concentration of the hormone (23). Thus, a lowered rate of efflux via pathway 2 is consistent with a lowered intracellular free hormone concentration. This may be explained by a lowered basolateral uptake (pathway 4) and/or by a lowered luminal uptake (pathway 3).
Inhibition of pathway 3 would result in augmented excretion of TH into the urine, which is evidently not the case in our study. Thus, it remains that inhibition of pathway 4 may be the cause for the decrease in pathway 2 via a decrease in intracellular free hormone concentration.
We showed that uptake of T 3 is diminished in perfused livers of fasted rats. Re-perfusion with energy-enriched perfusion medium restored T 3 uptake within half an hour (7), suggesting involvement of ATP in the transport process that is being lowered during fasting. In liver perfusions with fructose in the medium, ATP concentrations were diminished drastically and T 3 uptake decreased in parallel (10). These studies indicate that cellular ATP is a major determinant of cellular thyroid hormone uptake, as was found earlier in rat and human hepatocytes in culture (24, 25). In the present study, cellular kidney tubular ATP may also be lowered due to fasting.
As a result of fasting, serum concentrations of NEFA rise, as reported earlier (26, 27) . In a study with obese subjects undergoing caloric restriction, elevated NEFA concentrations in the sera of these subjects were found to be responsible for the inhibited T 4 uptake into rat hepatocytes (27) . Thus, elevated NEFA concentrations may, in addition to lowered cellular energy, be responsible for the suggested inhibition of pathway 4 (Fig. 2) .
In the proximal tubule, uric acid is both actively reabsorbed and secreted into the urine (28, 29) . In the fasted state, a developed ketoacidemia alters renal clearance of uric acid by an effect on these tubular transport mechanisms (28, 29) . These alterations cause a lowered urinary excretion, with subsequent elevated serum concentrations of uric acid (26, 28, 29) . The correlation between FT 3 renal clearance and uric acid clearance suggests that tubular handling of T 3 and uric acid may both be affected by similar mechanisms such as ketoacidosis or a decrease in cellular energy stores having similar or different transport pathways.
In this study, we used creatinine clearance (CrCl) as a marker for GFR, since CrCl values have been shown to correspond well with measured inulin clearances in fasting subjects on the third day of fasting in studies by others (30) (31) (32) . In the studies of Fox et al. (28) and Hoffman et al. (33) , GFR remains stable over three days of fasting, as in our study.
One of our subjects used oral contraceptives. These drugs are known to alter protein binding of thyroid hormones. Therefore, TT 3 and TT 4 were elevated, whereas free concentrations were normal. It can be questioned whether this medication may have induced alterations in renal handling of T 3 and T 4 in one of our fasting subjects. However, Gaitan et al. (15) reported unchanged urinary T 3 excretion in subjects using oral contraceptives, so it is unlikely that this drug interfered in our study, especially since excretion and clearance values of this subject were comparable to those of the other subjects.
In conclusion, fasting induced a significant decline in both T 3 and T 4 urinary excretion and renal clearances, which is, in addition to a decrease in serum FT 3 , consistent with inhibited uptake of T 3 and T 4 at the basolateral membrane of the proximal tubular cell. This uptake inhibition may be explained by lowered energy stores of the tubular cells or by other factors such as ketoacidosis and the detected elevation of serum NEFA levels. 
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